50 studies found for:    physical | urticaria
Show Display Options
Rank Status Study
21 Completed Phase II Solar Urticaria (SU) Pilot Study
Condition: Solar Urticaria
Intervention: Drug: afamelanotide
22 Not yet recruiting Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
Condition: Urticaria
Intervention: Drug: omalizumab
23 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
24 Recruiting Bilastine Updosing in Chronic Spontaneous Urticaria
Condition: Chronic Urticaria
Interventions: Drug: Bilastine;   Drug: Bilastin
25 Completed Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
Condition: Urticaria
Intervention: Drug: Alesion®
26 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
27 Suspended Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
Intervention:
28 Completed
Has Results
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Conditions: Familial Cold Autoinflammatory Syndrome (FCAS);   Familial Cold Urticaria;   Muckle-Wells Syndrome (MWS);   Genetic Diseases, Inborn
Interventions: Drug: rilonacept 160 mg;   Drug: Placebo
29 Not yet recruiting Hereditary AngioEdema, Neurobiology and Psychopathology
Conditions: Hereditary AngioEdema;   Anxiety;   Depression
Intervention: Other: Clinical and psychopathological assessment of HAE patients
30 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
Intervention:
31 Completed Cause and Natural Course of Pediatric-Onset Mastocytosis
Condition: Mastocytosis
Intervention:
32 Completed
Has Results
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
33 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
34 Terminated Effectiveness of Bradykinin Receptor Blocker at Reducing Swelling Associated With Angiotensin Converting Enzyme (ACE) Inhibitor-Associated Angioedema
Condition: Angioneurotic Edema
Interventions: Drug: HOE-140;   Other: Placebo
35 Completed Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis;   Anaphylaxis
Intervention:
36 Completed Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers
Condition: Hereditary Angioedema (HAE)
Intervention: Drug: Icatibant (30 mg)
37 Completed A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161
Condition: Hereditary Angioedema
Intervention: Drug: BCX4161
38 Active, not recruiting Study to Determine How BCX4161 is Metabolized and Eliminated by the Body
Condition: Hereditary Angioedema
Intervention: Drug: BCX4161
39 Completed Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus
Condition: Rhinitis, Allergic, Perennial
Intervention: Drug: Alesion®
40 Recruiting Study of Mast Cell Precursors
Condition: Mastocytosis
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results
Indicates status has not been verified in more than two years